Outside advisers to the US Food and Drug Administration (FDA) on Friday voted unanimously to recommend regulators authorize a second shot of Johnson & Johnson's COVID-19 vaccine to better protect Americans who received the one-dose vaccine, Reuters reports.
The FDA's Vaccines and Related Biological Products Advisory Committee backed the shots for all J&J recipients aged 18 and older at least two months after their first dose.
(Arutz Sheva’s North American desk is keeping you updated until the start of Shabbat in New York. The time posted automatically on all Arutz Sheva articles, however, is Israeli time.)
Read more